1/9/2014
Clinical trials--new antithrombotic drugs or hemostatic agents, development of diagnostic tests of coagulation and platelet function
2/9/2018
Large granular lymphocyte (LGL) leukemia, vitamin D, STAT proteins, inflammatory cytokines.
11/21/2015
Clinical trials in hematologic malignancies including leukemias and lymphomas, with special interest in determining optimal combinations and timing of targeted agents in B-cell leukemias and lymphomas.
11/21/2015
Development of cancer immunotherapy including cancer vaccines, immune checkpoint inhibitors and combination therapies, development of novel therapies in pancreatic and hepatobiliary cancers
11/21/2015
Gastrointestinal malignancies, cancer in the older adult, geriatric oncology.
5/9/2019
Dr. Singh research interests are focused on 1) developing innovative therapeutic approaches to suppress autoimmune diseases by chemokine and alternative medicine; 2) developing novel strategies to attenuate obesity and regulatory T cells (Tregs) expansion
